US2022177873A1PendingUtilityA1
Isolation and immobilization of nucleic acids and uses thereof
Est. expiryMay 26, 2040(~13.8 yrs left)· nominal 20-yr term from priority
Inventors:Brandon M. Young
C12N 15/1096C12N 15/1065C40B 50/18C12N 15/1006C12Q 1/6806
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a novel technique of directly isolating nucleic acids from a biological sample and use of the isolated nucleic acid complexes for various applications and assays such as biobanking and sequencing.
Claims
exact text as granted — not AI-modified1 .- 14 . (canceled)
15 . A method of generating a cDNA library from a biological sample, comprising:
obtaining a plurality of isolated nucleic acid fragments bound to a solid support; hybridizing one or more primers to the plurality of the isolated nucleic acid fragments; conducting primer extension using the plurality of the isolated nucleic acid fragments as templates to synthesize cDNA fragments; and eluting the synthesized cDNA fragments from the solid support to generate the cDNA library, wherein the plurality of the isolated nucleic acid fragments is obtained by contacting a biological sample containing the plurality of the nucleic acid fragments with a reaction mix comprising a template-independent DNA or RNA polymerase, and one or more NTPs, dNTPs or ddNTPs to obtain a tagged nucleic acid, wherein at least a fraction of the one or more NTPs, dNTPs or ddNTPs are modified by an affinity tag; binding the tagged nucleic acid fragments to a surface of a solid support; and washing the solid support to obtain the bound nucleic acid fragments isolated from the biological sample.
16 . The method of claim 15 , wherein the primer is a sense strand primer.
17 . The method of claim 15 , wherein the primer is an anti-sense strand primer.
18 . The method of claim 15 , wherein the primer is a specific primer.
19 . The method of claim 15 , wherein the primer is a random primer.
20 . The method of claim 15 , wherein the one or more primers bind to different nucleic acid fragments.
21 . The method of claim 15 , wherein the one or more primers bind to different locations of a nucleic acid fragment.
22 . The method of claim 15 , wherein the one or more primers bind to the same location of different nucleic acid fragments.
23 . The method of claim 15 , further comprising:
annealing the eluted sense strand cDNA fragments and anti-sense strand cDNA fragments; and extending the annealed cDNA fragments to fill in the gap thereby to obtain double stranded cDNA fragments.
24 . A captured nucleic acid complex comprising:
a solid support; and a plurality of nucleic acid fragments, each fragment having a 3′ end bound to a polymeric tail, and each polymeric tail is bound to a surface of the solid support.
25 - 31 . (canceled)
32 . A biobank comprising a plurality of the complexes of claim 24 .
33 . The biobank of claim 32 , wherein the plurality of the complexes comprises the DNA of the entire genome.
34 . The biobank of claim 32 , wherein the plurality of the complexes comprises the DNA of substantially the entire genome.
35 . The method of claim 15 , wherein the biological sample is selected from the group consisting of blood, plasma, serum, urine, saliva, exosome, a lysed formalin-fixed, paraffin-embedded (FFPE) tissue sample, and cells.
36 . The method of claim 15 , wherein the nucleic acid fragments are DNA fragments, RNA fragments, or a mixture of both.
37 . The method of claim 15 , wherein the nucleic acid fragments are double-stranded, single-stranded, or a mixture of both.
38 . The method of claim 37 , wherein the double-stranded nucleic acid fragments are denatured to single-stranded nucleic acid fragments before or after contacting the biological sample with the reaction mix.
39 . The method of claim 15 , wherein the template-independent DNA or RNA polymerase is terminal transferase (TdT).
40 . The method of claim 15 , wherein the affinity tag is biotin, and the surface of the solid support is coated with avidin, streptavidin, or neutravidin.
41 . The method of claim 15 , wherein the reaction mix comprises biotinylated dUTP or biotinylated ddUTP.
42 . The method of claim 15 , wherein a polymeric tail comprising the unmodified and modified NTPs, dNTPs or ddNTPs is attached to a 3′ end of the nucleic acid fragments.
43 . The method of claim 15 , wherein the solid support is a bead, a plate, or a column.Join the waitlist — get patent alerts
Track US2022177873A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.